Radar › Companies › Genomics · Ireland
Radar · Genomics in Ireland

Best Genomics Companies in Ireland

The 35 best Genomics companies in Ireland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Aerska.

35companies tracked
$152.1Mdisclosed funding
0unicorns
22have raised
Sources & further reading
  • Genomics Market Surges with PCR and AI Technologies Projected to Reach
  • Genomics Market Size to Grow by USD 18,244.34 million from 2022 to 202
FLIAR INTELLIGENCE · GENOMICS × IRELAND

Our analysis of 50 Genomics companies

$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

50companies analysed
84%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2016median founding year

Ranked: Best Genomics companies in Ireland

#CompanyDisclosed fundingLast roundStageEmployeesFounderTech stackPatents & IP focusRecent signals
1Aerska
Developer of RNAi medicines, delivered systemically, for treating brain diseases
$60M7 mo agoSeries A—David Hardwicke
Co-Founder & Director & Head of Business Development
WebflowGSAPMicrosoft Advertising+11—1 award
2Avectas
Provider of non-viral cell engineering technology platform for drug discovery
$33M76 mo agoSeries C35Michael Maguire
Co-Founder & CEO
WebflowGSAPAmazon Web Services+12102 patents
Non‑viral intracellular delivery platforms for biomolecules via membrane permeabilization and flow‑through systems
—
3IdentiGEN
Data-driven solutions for animal health, food safety, and traceability
$15M137 mo agoAcquired60——41 patents
Automated biological sample collection, sequencing prep, and traceability for livestock genomics
—
4HiberGene
Developer of molecular diagnostic tests for detecting human infectious diseases
$14M77 mo agoDeadpooled12————
5Genable Technologies
Provider of gene therapy to treat Retinitis pigmentosa
$8M178 mo agoAcquired5Paul Kenna
Co-Founder
———
6OncoMark
Provider of tissue-based diagnostics for cancer
$7M86 mo agoAcqui-Hired5————
7Akkure
Provider of a blockchain technology based online platform for genomic data analytics
$3M46 mo agoSeed9Amy Hollingworth
Co-Founder
———
8Helixworks
Developer of DNA-based data storage solutions
$2M52 mo agoSeed6————
9GlowDx
Developer of point-of-care diagnostics for infectious diseases
$2M73 mo agoSeed16————
10Microsynbiotix
Blue biotech venture developing biological solutions for aquatic ecosystem problems
$1M108 mo agoAcqui-Hired3——3 patents
Recombinant DNA production of therapeutic polypeptides for animal vaccine applications
—
11CYGENICA
Developer of in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics
$1M63 mo agoSeed5Nusrat Sanghamitra
Founder & CEO
PHPBootstrapApache HTTP Server+66 patents
Membrane-penetrating conjugates for intracellular delivery of gene‑editing agents
—
12Algae Health
Produces bio actives from microalgae
$1M163 mo agoDeadpooled11Edward McHugh
Founder & MD
—3 patents
Algal cultivation systems and photobioreactor technologies for biomass production
—
13BioProbe Diagnostics
Nucleic Acid diagnostics for microbial detection and identification
$1M77 mo agoFunding Raised6Ciaran Geoghegan
Founder & CEO
———
14Magnostics
Developer of nano-diagnostics and magnetic beads for serious illnesses
$769K69 mo agoFunding Raised—Gil Lee
Director and Co-founder
—3 patents
Functionalized magnetic silica beads for biomedical diagnostics and intestinal disease therapy
—
15OmniSpirant
Developing inhaled regenerative gene therapy for cystic fibrosis and COPD
$309K51 mo agoFunding Raised—Gerry Mccauley
CEO
—17 patents
Inhalable extracellular vesicle drug delivery for respiratory therapies
—
16Cell Free Tech
Provider of tools and services for DNA and protein applications
$296K105 mo agoDeadpooled—Thomas Meany
Co-Founder & CEO
———
17Empiric Logic
Provider of cloud-based bioinformatics platform for managing healthcare data
$101K66 mo agoDeadpooled—Gareth OSullivan
CEO
———

Top 12 Genomics companies in Ireland

#1
Series A · Dublin, County Dublin · founded 2025
$60Mraised
▾

Developer of RNAi medicines, delivered systemically, for treating brain diseases. It focuses on targeted delivery of RNA medicines to silence genes causing harm. The company aims to preserve minds, protect memories, and enable healthier lives. It combines target biology, data-driven patient stratification, and biomarker-guided development.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 18.8% of this cohort's audience
Activity: 1 awards · 1 expansions announced in 12 mo
Funding rounds
  • Feb 2026Series A$39M
  • Oct 2025Seed$21M
  • 2025Seed—
Founders & team
David HardwickeCo-Founder & Director & Head of Business DevelopmentStuart MilsteinCo-Founder
Investors
age1, Backed, Speedinvest, BlueYard, Lingotto, Norrsken VC
Tech stack
CloudflareCookiebotGoogle Tag ManagerGsapHstsHttp/3
#2
Series C · Dublin, Leinster · founded 2011 · 35 employees
$33.5Mraised
▾

Provider of non-viral cell engineering technology platform for drug discovery. The company has developed proprietary technology SOLUPORE that enables the delivery of nucleic acids such as mRNA, DNA, and proteins, including gene-editing tools such as CRISPR to cells and tissues with application in ex vivo and in vivo gene editing.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 17.4% of this cohort's audience
Activity: 1 partnerships (incl. CCRM and OmniaBio) announced in 12 mo
Funding rounds
  • Apr 2020Grant (prize money)$542.9K
  • Apr 2020Series C$20M
  • Apr 2019Angel$13.5M
  • May 2018Grant (prize money)$2.5M
Founders & team
Michael MaguireCo-Founder & CEO
Investors
Europa, EIC Fund
Tech stack
CloudflareContact Form 7Cookie ScriptGoogle Font ApiGoogle Hosted LibrariesGoogle Tag Manager
#3
Deadpooled · Dublin, County Dublin · founded 2009 · 12 employees
$14.3Mraised
▾

Developer of molecular diagnostic tests for detecting human infectious diseases. The company has developed a device that uses LAMP (Loop-Mediated Isothermal Amplification) technology to detect Meningococcus, group B Streptococcus, C. difficile, Mycoplasma pneumonia, Pneumococcus, Meningococcus, and Influenza A & B. The company claims to develop and launch tests for RSV A & B Chlamydia & Gonorrhoea.

Funding rounds
  • Apr 2020Series B—
  • Apr 2020Grant (prize money)$1.1M
  • Feb 2020Grant (prize money)$698K
  • Apr 2017Series B$7.1M
Investors
Kernel Capital, Cantor Fitzgerald, Medcaptain, Shackleton Ventures, EIC Fund, Enterprise Ireland
#4
Seed · Dublin, Leinster · founded 2016 · 9 employees
$3.4Mraised
▾

Akkure is an online platform for genomics data analytics. The platform enables the user to control, manage data or provide rewards for sharing data. It also enables researchers to connect with organizations to order DNA test kits for genomics sequencing, receive results, and analyze genomics data. The company uses blockchain-based technology in order to share and manage research data analytics.

Funding rounds
  • Nov 2022Grant (prize money)$718.1K
  • 2021Seed$1.9M
  • Jan 2021Seed$1.4M
Founders & team
Amy HollingworthCo-FounderOran RigbyCo-Founder
Investors
Enterprise Ireland, Digital Transformation Innovation Fund
#5
Acquired · Dublin, Leinster · founded 1996 · 60 employees
$15.4Mraised
▾

Data-driven solutions for animal health, food safety, and traceability. They offer technology solutions fusing DNA and data intelligence, providing animal lifecycle knowledge and insightful connections. The company empowers better choices through actionable data, supporting sustainability and brand differentiation. Their platforms, DNA TraceBack and DataLive, deliver food and animal knowledge, enabling sustainable decisions and consumer trust. They partner with various industries, offering end-to-end solutions for a transparent food supply chain and improved animal wellbeing. This is a B2B tech company offering software solutions for traceability, animal health, and food safety, promoting a more sustainable food supply and healthier animals.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers — 20.5% of this cohort's audience
Activity: 2 product launches · 1 partnerships (incl. Vion Food Group) announced in 12 mo
Funding rounds
  • Apr 2015Series B$12.9M
  • Sep 2005Series A$2.5M
Investors
MML, 4th Level Ventures
Tech stack
WordpressMysqlPhpGutenbergYoast Seo PremiumBackbone.Js
#6
Acqui-Hired · Dublin, Leinster · founded 2011 · 5 employees
$6.7Mraised
▾

Oncomark develops tissue-based diagnostics for cancer. The company's flagship product OncoMasTR qPCR assay uses various genes and control genes to give the prognostic risk of recurrence in early-stage breast cancer patients. In addition, the company is developing products for melanoma, colorectal cancer, and prostate cancer.

Funding rounds
  • Jul 2019Series A$4.5M
  • Feb 2017Seed$2.2M
  • Feb 2016Grant (prize money)$3M
  • Sep 2015Grant (prize money)$3M
Investors
Irrus Investments, Halo Business Angel Network, European Innovation Council, Europa, Kernel Capital, Enterprise Ireland
#7
Seed · Cork, Munster · founded 2016 · 6 employees
$2.3Mraised
▾

Developer of DNA-based data storage solutions. It involves encoding digital data into synthetic DNA strands for dense storage medium. The technology is applicable to diverse data types, from genomic information to large digital files.

Funding rounds
  • May 2022Grant (prize money)$1.8M
  • Oct 2019Grant (prize money)$487.1K
  • Jun 2019Grant (prize money)—
  • Feb 2019Seed—
Investors
dlab, Europa, European Innovation Council, SOSV, IKP Knowledge Park, BIRAC
Tech stack
Cart FunctionalitySquarespace CommerceSquarespaceStimulusLinkedin Insight TagLinkedin Ads
#8
Acquired · Dublin, Leinster · founded 2001 · 5 employees
$8.1Mraised
▾

Provider of gene therapy to treat Retinitis pigmentosa. The first gene medicine - RhoNova formerly known as GT038 - is for the treatment of patients with rhodopsin (RHO)-linked adRP - a debilitating form of inherited blindness resulting from a diverse array of mutations in the RHO gene. It utilizes AAV vectors to obtain expression of RNA interference (RNAi) molecules which suppress the expression of both the faulty and normal gene copies and replaces this with a gene subtly altered to become refractory to suppression but still encoding a normal wild type protein.

Funding rounds
  • Nov 2011Series B$6.8M
  • Sep 2004Series A$1.3M
Founders & team
Paul KennaCo-FounderJane FarrarCo-Founder
Investors
Delta Partners, Fountain Healthcare Partners, Furthr
Tech stack
CloudflareHttp/3
#9
Seed · Cork, Munster · founded 2015 · 16 employees
$1.6Mraised
▾

Developer of point-of-care diagnostics for infectious diseases. The company utilizes AI and machine learning to develop tests that detects mosquito-borne infections such as dengue fever, chikungunya & zika virus.

Funding rounds
  • Jul 2020Seed$1.3M
  • Feb 2019Seed$107.4K
  • Jul 2015Seed$250K
  • 2015Seed—
Investors
SOSV, IndieBio, BioExel, Enterprise Ireland
Tech stack
WixReactGoogle CloudPolyfillLodashPriority Hints
#10
Seed · Ballincollig, County Cork · founded 2017 · 5 employees
$1.4Mraised
▾

Developer of in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics. The company's platform is an engineered negatively charged protein molecule that translocates through the cell membrane using a non- endocytic helical mechanism.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers — 11.1% of this cohort's audience · 25 engagements/post (2.7× cohort median)
Hiring: 1 hiring post in 12 mo (public) · hiring: Project Management Associate
Activity: 1 expansions announced in 12 mo
Funding rounds
  • Jun 2021Seed$1.4M
  • 2017Seed—
  • Grant (prize money)—
Founders & team
Nusrat SanghamitraFounder & CEO
Investors
SOSV, Voyagers, BIRAC, empoWer
Tech stack
Animate.CssApache Http ServerBootstrapFont AwesomeFullpage.JsGodaddy
#11
Funding Raised · Galway, Connaught · founded 2017 · 6 employees
$1Mraised
▾

BioProbe Diagnostics is a spin-out company from NUI Galway established to commercialise proprietary nucleic acid diagnostics for the detection and identification of microbial contaminants. The company is currently focused on bringing its first product, called Leg-ID, to market. Leg-ID is designed to enable the reliable diagnosis of Legionella infections.

Funding rounds
  • Apr 2020Grant (prize money)$925K
  • Nov 2018Grant (prize money)$56.9K
  • Jun 2018Grant (prize money)$58.3K
Founders & team
Ciaran GeogheganFounder & CEO
Investors
Europa, EIC Fund, BioExel
#12
Acqui-Hired · Cork, Munster · founded 2016 · 3 employees
$1.4Mraised
▾

Blue biotech venture developing biological solutions for aquatic ecosystem problems. The company creates biological products using precision fermentation and engineered biology to address major aquatic challenges. They focus on developing natural actives from marine organisms and high-performance microalgal delivery systems. Their development pipeline includes solutions for aquatic pests, diseases, hazardous algal blooms, and aquatic invasive species. The company aims to provide effective, economical, robust, and environmentally benign solutions for the blue economy, offering tools that solve problems without creating new ones. They are committed to innovation and sustainability in the aquatic environment.

Funding rounds
  • Sep 2017Seed$1.2M
  • May 2017Seed$112K
  • Jun 2016Seed$100K
Investors
The Yield Lab, Alimentos Ventures, SOSV, Enterprise Ireland, IndieBio
Tech stack
Cart FunctionalitySquarespace CommerceSquarespaceStimulusPriority HintsGoogle Font Api

Funding & investor landscape

$152.1Mtotal disclosed funding
19companies funded
46disclosed rounds
0rounds last 90 days
Most active investors
Europa8 rounds
SOSV7 rounds
Enterprise Ireland5 rounds
EIC Fund4 rounds
BIRAC2 rounds
BioExel2 rounds
European Innovation Council2 rounds
IndieBio2 rounds
Irrus Investments2 rounds
Kernel Capital2 rounds

Notable founders

David Hardwicke
Co-Founder & Director & Head of Business Development · Aerska
Stuart Milstein
Co-Founder · Aerska
Michael Maguire
Co-Founder & CEO · Avectas
Amy Hollingworth
Co-Founder · Akkure
Oran Rigby
Co-Founder · Akkure
Paul Kenna
Co-Founder · Genable Technologies
Jane Farrar
Co-Founder · Genable Technologies
Nusrat Sanghamitra
Founder & CEO · CYGENICA
Ciaran Geoghegan
Founder & CEO · BioProbe Diagnostics
Gerry Mccauley
CEO · OmniSpirant
Gil Lee
Director and Co-founder · Magnostics
Ben Sprangers
Founder and Chief Medical Officer · Magnostics
Prism market signals · Ireland · country-scoped Prism corpus, 702,813 docs

Market landscape — 10 sub-themes by coverage

Share of Genomics coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding flat · growth rising

RESEARCH SIGNALS · Ireland

How research on Bioinformatics is moving in Ireland

A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 253 Ireland-affiliated papers.

top research entities
  • University College Cork40
  • University College Dublin33
  • APC Microbiome Institute29
  • Ollscoil na Gaillimhe – University of Galway25
  • Department of Health24
leading researchers
John F. Cryan · Gerard Clarke · Charlie F Rowlands · Sophie Allen · Timothy G. Dinan · Marcus J. Claesson · Alice Garrett · Ian B. Jeffery
▲ Breakthroughs65 · 26%
▲ 0%→26% share
0 median citations89% since 2021mostly methods-led
Breakthroughs are rising (0%→26% of field), led by Population.
rising sub-themes (early→recent)
  • Population1→5
  • Metagenomics1→4
  • Gene2→5
  • Transcriptome2→4
Newly emergingGenome 0→6
Landmark Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking · 4,422 cites
◆ Advancements84 · 33%
▲ 0%→35% share
0 median citations90% since 2021mostly empirical
Advancements are rising (0%→35% of field), led by Disease.
rising sub-themes (early→recent)
  • Disease1→8
  • In silico1→4
Newly emergingImmune system 0→8 · Cancer 0→7 · Gene 0→7
Landmark Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment · 2,561 cites
▼ Concerns60 · 24%
▲ 0%→23% share
0 median citations85% since 2021mostly reviews
Concerns are rising (0%→23% of field), led by Disease.
rising sub-themes (early→recent)
  • Disease2→8
Newly emergingCancer 0→6 · Immune system 0→5 · MEDLINE 0→5
Landmark Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Infor · 2,048 cites
RESEARCH HOTSPOTS · Ireland

Where bioinformatics is researched across Ireland

Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.

Cork94 · +0.36
Hot · MicrobiomeAdvancing · TranscriptomeOpportunity · Identification (biology)Concern · Gut–brain axis
Dublin92 · +0.33
Hot · MEDLINEAdvancing · CancerOpportunity · GenomeConcern · Immune system
Galway27 · +0.24
Hot · GenomeOpportunity · Gene
Carlow16 · +0.49
Hot · MicrobiomeOpportunity · Gene
Limerick6 · +0.30
Opportunity · Disease
Maynooth6 · +0.50

Common questions

How many Genomics companies are there in Ireland?
Radar tracks 35 indexable Genomics companies headquartered in Ireland that meet our profile-completeness bar.
What is the total funding raised by Genomics companies in Ireland?
The Genomics companies in Ireland on this list have raised a combined $152.1M in disclosed equity funding across 19 funded companies.
Which is the highest-funded Genomics company in Ireland?
Aerska is the highest-funded Genomics company in Ireland, with $60M in disclosed equity funding.
How many Genomics companies in Ireland are funded?
19 of the 35 Genomics companies in Ireland on this list have disclosed at least one equity funding round.
How many Genomics unicorns are there in Ireland?
None of the Genomics companies in Ireland on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Ireland Genomics companies?
The most active investors in Ireland Genomics companies on this list include Europa, SOSV, Enterprise Ireland, EIC Fund, BIRAC.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon